Cargando…
Secoisolariciresinol diglucoside regulates estrogen receptor expression to ameliorate OVX-induced osteoporosis
OBJECTIVE: Secoisolariciresinol diglucoside (SDG) is a phytoestrogen that has been reported to improve postmenopausal osteoporosis (PMOP) caused by estrogen deficiency. In our work, we aimed to investigate the mechanism of SDG in regulating the expressions of ERs on PMOP model rats. METHODS: Ovariec...
Autores principales: | Chen, Guofang, Chen, Yansong, Hong, Junyi, Gao, Junwei, Xu, Zhikun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10594807/ https://www.ncbi.nlm.nih.gov/pubmed/37875947 http://dx.doi.org/10.1186/s13018-023-04284-5 |
Ejemplares similares
-
Potential protective properties of flax lignan secoisolariciresinol diglucoside
por: Imran, Muhammad, et al.
Publicado: (2015) -
Secoisolariciresinol Diglucoside of Flaxseed and Its Metabolites: Biosynthesis and Potential for Nutraceuticals
por: Kezimana, Parfait, et al.
Publicado: (2018) -
Secoisolariciresinol diglucoside and anethole ameliorate lipid abnormalities, oxidative injury, hypercholesterolemia, heart, and liver conditions
por: Noreen, Sana, et al.
Publicado: (2023) -
Secoisolariciresinol Diglucoside Improves Ovarian Reserve in Aging Mouse by Inhibiting Oxidative Stress
por: He, XueLai, et al.
Publicado: (2022) -
Identification and functional characterization of a flax UDP-glycosyltransferase glucosylating secoisolariciresinol (SECO) into secoisolariciresinol monoglucoside (SMG) and diglucoside (SDG)
por: Ghose, Kaushik, et al.
Publicado: (2014)